Norton Rose Fulbright adds cutting-edge technology and life sciences team in San Francisco, … | News

San Francisco, February 22, 2022 (GLOBE NEWSWIRE) – World law firm Norton Rose Fulbright announced today that it has been joined by a team of life and intellectual property experts, including San Francisco partners Roger Kuan and Jason Newbie. Together, they will run a company in digital health and precision medicine, representing pharmaceutical, biotech and health insurance companies, as well as technology startups and industry investors. Associate Dagim Tilahun and patent agent Noble Wu complement the team that arrived.

Joining with Haynes and Boone, Kuan and Novak are highly skilled in handling intellectual property transactions for both startups and large companies, providing a range of services related to technology transactions, IP consulting and portfolio management. Earlier in their careers, Kuan and Novak both held senior positions at Thermo Fisher Scientific.

Jeff Cody, managing partner of Norton Rose Fulbright in the US, said:

“We’ve preferred growth in California, and this team fits perfectly into our expansion strategy. Both Roger and Jason have an entrepreneurial mind with innovative approaches to their practice. We are excited to welcome them and this new practice of digital health and precision medicine by Norton Rose Fulbright. ”

Jim Repas, head of Norton Rose Fulbright’s U.S. intellectual property division, said:

“Roger and Jason have extensive experience in biotech, medical and pharmaceutical companies, giving them a unique understanding of their clients’ businesses. We know that their prospects will greatly expand the breadth of our intellectual property, and we expect that their arrival will present the firm with many promising opportunities. ”

Kuan advises companies that occupy a unique position in the convergence of the life / health sciences and technology industries on how to successfully navigate the complexities of intellectual property and the regulatory issues they face. He has extensive experience in IP portfolio strategy and management (utility / design patents, trademarks, copyrights and trademarks), licensing and technology transactions, operating licenses, law enforcement, monetization, proper IP verification and dispute resolution.

Kuan, who will be Norton Rose Fulbright’s head of digital health and precision medicine practice in the United States, said:

“Norton Rose Fulbright’s global platform and its life sciences and health science practices are unmatched and provide an exciting opportunity to offer clients dynamic resources while expanding our practice. I am happy to work with our new colleagues both in the United States and on a truly international scale. “

Novak advises on a variety of legal issues arising with new technologies in life sciences and healthcare. He also has extensive experience in strategy and patent portfolio management in the field of IP, preparation and prosecution, opposition, consulting, licensing and technology transactions, licensing inside and outside, freedom of work, various types of due diligence, training in IP , risk recognition as well as management and dispute resolution.

Novak, who is often an author and speaker on intellectual property and life sciences, said:

“The most advanced technologies are responsible for many of our new digital healthcare capabilities and also cause unique legal challenges. I look forward to continuing our customer service in this exciting and evolving industry with the extensive support of Norton Rose Fulbright. ”

Licensed to California and the U.S. Patent and Trademark Office (USPTO), Kuan earned a law degree from the University of Santa Clara School of Law, a master’s degree in environmental engineering with a focus on biochemical engineering from California State University, and the Polytechnic of San Diego University. -Obispa and his Bachelor of Toxicology degree from the University of California, Davis.

Novak, who is licensed in California, Illinois and at the USPTO, received a law degree from the Chicago-Kent College of Law and a bachelor’s degree in chemical engineering with honors from the Illinois Institute of Technology.

Tilahun was licensed in New York City and earned a law degree from Fordham University Law School, a doctorate in physics from the University of Texas at Austin and a bachelor’s degree in physics from Hendrix College. He was also a graduate student at the Cowley Institute of Theoretical Physics at the University of California, Santa Barbara.

Wu received a doctorate in applied physics and materials science with a focus on measuring systems based on optics at Cornell University and a master’s degree in physical chemistry / materials science at Cornell University. He received a bachelor’s degree in physics from the University of California, San Diego.

Attachments

Roger Quan Jason Novak

Dan McKenna Norton Rose Fulbright 7136513576 dan.mckenna@nortonrosefulbright.com

Copyright 2022 GlobeNewswire, Inc.

.

Leave a Comment